 The stock price of Alnylam Pharmaceuticals, a relatively smaller pharmaceutical company with a market capitalization of 18 billion, has seen a 22 rise over the last twenty-one trading days, and we believe the stock will likely continue to rally in the near term. The 22 rise can primarily be. 